Current and future pharmacological agents for the treatment of back pain

References

• Shmagel A, Foley R, Ibrahim H. Epidemiology of chronic low back pain in US adults: data from the 2009–2010 national health and nutrition examination survey. Arthritis Care Res (Hoboken). 2016;68(11):1688–1694.
   PubMed Web of Science ®Google Scholar
• GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017.Lancet.2018 (101549);392:1789–1858.
   PubMed Web of Science ®Google Scholar
• Foster NE, Anema JR, Cherkin D, et al. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet. 2018 (10137);391:2368–2383.
   PubMed Web of Science ®Google Scholar
• Crow W, Willis D. Estimating cost of care for patients with acute low back pain: a retrospective review of patient records. J Am Osteopath Assoc. 2009;109(4):229–233.
   PubMedGoogle Scholar
• for the Clinical Guidelines Committee of the American College of Physicians, Qaseem A, Wilt TJ, McLean RM, et al. Noninvasive treatments for acute, subacute, and chronic low back pain. a clinical practice guideline from the American college of physicians. Ann Intern Med. 2017;166(7):514–530.
   PubMed Web of Science ®Google Scholar
• von Korff M, Saunders K. The course of back pain in primary care. Spine (Phila Pa 1976). 1996;21(24):2833–2837.
   PubMed Web of Science ®Google Scholar
• Hüllemann P, Keller T, Kabelitz M, et al. Clinical manifestation of acute, subacute, and chronic low back pain in different age groups: low back pain in 35,446 patients. Pain Pract. 2018;18(8):1011–1023.
   PubMed Web of Science ®Google Scholar
• Kosek E, Cohen M, Baron R, et al. Do we need a third mechanistic descriptor for chronic pain states? Pain. 2016;157(7):1382–1386.
   PubMed Web of Science ®Google Scholar
• Cohen SP, Doshi TL, Dawson TC, et al. Prognostic value of hypersensitivity reactions on epidural steroid injection outcomes: a phenotypic signature? A prospective cohort study. Reg Anesth Pain Med. 2019;44(5):586–594.
   PubMed Web of Science ®Google Scholar
• Maher C, Underwood M, Buchbinder R. Non-specific low back pain. Lancet. 2017;389(10070):736–747.
   PubMed Web of Science ®Google Scholar
• Woolf CJ, Max MB. Mechanism-based pain diagnosis: issues for analgesic drug development. Anesthesiology. 2001;95(1):241–249.
   PubMed Web of Science ®Google Scholar
• Shmagel A, Ngo L, Ensrud K, et al. Prescription medication use among community-based U.S. adults with chronic low back pain: a cross-sectional population-based study. J Pain. 2018;19(10):1104–1112.
   PubMed Web of Science ®Google Scholar
• Romano CL, Romano D, Bonora C, et al. Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain. J Orthop Traumatol. 2009;10(4):185–191.
   PubMedGoogle Scholar
• Enthoven WT, Roelofs PD, Deyo RA, et al. Non-steroidal anti-inflammatory drugs for chronic low back pain. Cochrane Database Syst Rev. 2016;2:CD012087.
   PubMed Web of Science ®Google Scholar
• Skljarevski V, Zhang S, Desaiah D, et al. Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial. J Pain. 2010;11(12):1282–1290.
   PubMed Web of Science ®Google Scholar
• McCrae JC, Morrison EE, MacIntyre IM, et al. Long-term adverse effects of paracetamol - a review. Br J Clin Pharmacol. 2018;84(10):2218–2230.
   PubMed Web of Science ®Google Scholar
• Machado GC, Maher CG, Ferreira PH, et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomized placebo-controlled trials. BMJ. 2015;350:h1225.
   PubMed Web of Science ®Google Scholar
• Chou R, Deyo R, Friedly J, et al. Systemic pharmacologic therapies for low back pain: A systematic review for an American college of physicians clinical practice guideline. Ann Intern Med. 2017;166(7):480–492.
   PubMed Web of Science ®Google Scholar
• Moulin D, Boulanger A, Clark AJ, et al. Canadian pain society. Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian pain society. Pain Res Manag. 2014;19(6):328–335.
   PubMed Web of Science ®Google Scholar
• Rasmussen-Barr E, Held U, Grooten WJ, et al. Non-steroidal anti-inflammatory drugs for sciatica. Cochrane Database Syst Rev. 2016;10:CD012382.
   PubMedGoogle Scholar
• Abdel Shaheed C, Maher C, Williams KA, et al. Efficacy and tolerability of muscle relaxants for low back pain: systematic review and meta-analysis. Eur J Pain. 2017;21(2):228–237.
   PubMed Web of Science ®Google Scholar
• Cohen SP. Benzodiazepines for back pain: when the cure is worse than the disease. Pain. 2010;149:424–425.
   PubMed Web of Science ®Google Scholar
• Shanthanna H, Gilron I, Rajarathinam M, et al. Benefits and safety of gabapentinoids in chronic low back pain: A systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2017;14(8):e1002369.
   PubMed Web of Science ®Google Scholar
• Robertson K, Marshman LG, Plummer D, et al. Effect of gabapentin vs pregabalin on pain intensity in adults with chronic sciatica: a randomized clinical trial. JAMA Neurol. 2019;76(1):28–34.
   PubMed Web of Science ®Google Scholar
• Schukro RP, Oehmke MJ, Geroldinger A, et al. Efficacy of duloxetine in chronic low back pain with a neuropathic component: A randomized, double-blind, placebo-controlled crossover trial. Anesthesiology. 2016;124:150–158.
   PubMed Web of Science ®Google Scholar
• Chaparro LE, Furlan AD, Deshpande A, et al. Opioids compared with placebo or other treatments for chronic low back pain: an update of the Cochrane review. Spine (Phila Pa 1976). 2014;39(7):556–563.
   PubMed Web of Science ®Google Scholar
• Abdel Shaheed C, Maher CG, Williams KA, et al. Efficacy, tolerability, and dose-dependent effects of opioid analgesics for low back pain: a systematic review and meta-analysis. JAMA Intern Med. 2016;176(7):958–968.
   PubMed Web of Science ®Google Scholar
• Thornton JD, Goyat R, Dwibedi N, et al. Health-related quality of life in patients receiving long-term opioid therapy: a systematic review with meta-analysis. Qual Life Res. 2017;26(8):1955–1967.
   PubMed Web of Science ®Google Scholar
• Sanger N, Bhatt M, Singhal N, et al. Adverse outcomes associated with prescription opioids for acute low back pain: a systematic review and meta-analysis. Pain Physician. 2019;22(2):119–138.
   PubMed Web of Science ®Google Scholar